Coherus Oncology (CHRS) Institutional Ownership $1.48 -0.01 (-0.34%) As of 11:19 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Coherus Oncology (NASDAQ:CHRS)CurrentInstitutional OwnershipPercentage72.82%Number ofInstitutional Buyers(last 12 months)41TotalInstitutional Inflows(last 12 months)$6.34MNumber ofInstitutional Sellers(last 12 months)22TotalInstitutional Outflows(last 12 months)$9.39M Get CHRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Coherus Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CHRS Institutional Buying and Selling by Quarter Coherus Oncology Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2026 Renaissance Technologies LLC331,700$561K0.0%+140.5%0.215% 5/14/2026 Sei Investments Co.453,763$767K0.0%+492.2%0.294% 5/13/2026 Cetera Investment Advisers31,685$54K0.0%N/A0.021% 5/7/2026 Dimensional Fund Advisors LP35,397$60K0.0%N/A0.023% 5/5/2026 Bank of New York Mellon Corp285,033$482K0.0%-2.0%0.185% 4/27/2026 Simplify Asset Management Inc.253,140$428K0.0%N/A0.164% 4/16/2026 Diversified Trust Co38,471$65K0.0%+36.6%0.026% 2/19/2026 Invesco Ltd.380,033$540K0.0%+45.6%0.314% 2/18/2026 XTX Topco Ltd166,797$237K0.0%+71.6%0.138% 2/18/2026 Tang Capital Management LLC2,724,509$3.87M0.2%-46.6%2.254% Get the Latest News and Ratings for CHRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coherus Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/18/2026 Millennium Management LLC660,451$938K0.0%N/A0.546% 2/18/2026 Bridgeway Capital Management LLC441,000$626K0.0%+72.9%0.365% 2/17/2026 AQR Capital Management LLC885,720$1.26M0.0%-1.9%0.733% 2/17/2026 Blair William & Co. IL19,000$27K0.0%N/A0.016% 2/16/2026 Squarepoint Ops LLC92,756$132K0.0%N/A0.077% 2/16/2026 Panagora Asset Management Inc.1,620,271$2.30M0.0%+17.8%1.341% 2/16/2026 Barclays PLC345,573$491K0.0%+17.9%0.286% 2/13/2026 Marshall Wace LLP85,464$121K0.0%N/A0.071% 2/13/2026 Hudson Bay Capital Management LP835,000$1.19M0.0%+3.1%0.691% 2/13/2026 Charles Schwab Investment Management Inc.935,239$1.33M0.0%-5.8%0.774% 2/13/2026 Ieq Capital LLC79,128$112K0.0%+24.9%0.065% 2/13/2026 Wells Fargo & Company MN117,975$168K0.0%+55.1%0.098% 2/12/2026 Renaissance Technologies LLC137,900$196K0.0%+472.2%0.114% 2/12/2026 Nuveen LLC210,379$299K0.0%+57.3%0.174% 2/11/2026 Deutsche Bank AG71,762$102K0.0%-39.2%0.059% 2/11/2026 LPL Financial LLC98,541$140K0.0%-68.1%0.082% 2/11/2026 O Shaughnessy Asset Management LLC37,207$53K0.0%-41.1%0.031% 2/11/2026 Los Angeles Capital Management LLC131,360$187K0.0%+49.4%0.109% 2/10/2026 Goldman Sachs Group Inc.307,137$436K0.0%-19.8%0.254% 2/9/2026Jefferies Financial Group Inc.395,190$561K0.0%+21.4%0.327% 2/6/2026 ProShare Advisors LLC24,718$35K0.0%+36.3%0.020% 2/3/2026 Bronte Capital Management Pty Ltd.19,282$27K0.0%N/A0.016% 1/29/2026 Kestra Private Wealth Services LLC20,000$28K0.0%N/A0.017% 1/29/2026 China Universal Asset Management Co. Ltd.19,696$28K0.0%N/A0.016% 1/26/2026 CWM LLC40,334$57K0.0%+13.8%0.033% 1/23/2026 Tyche Wealth Partners LLC220,868$314K0.0%+12.8%0.183% 1/9/2026 SG Americas Securities LLC34,436$49K0.0%+188.3%0.028% 12/15/2025 Hudson Bay Capital Management LP810,000$1.33M0.0%-3.0%0.670% 11/17/2025 Quarry LP15,572$26K0.0%N/A0.013% 11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.49,280$81K0.0%-22.8%0.041% The 1934 playbook (Ad)In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.Get the free report now11/17/2025 Focus Partners Wealth42,986$70K0.0%N/A0.036% 11/14/2025 Two Sigma Investments LP35,712$59K0.0%N/A0.030% 11/14/2025 Bridgeway Capital Management LLC255,000$418K0.0%+78.3%0.211% 11/13/2025 UBS Group AG795,941$1.31M0.0%+38.5%0.659% 11/13/2025 BNP Paribas Financial Markets26,620$44K0.0%+108.2%0.022% 11/13/2025Jefferies Financial Group Inc.325,625$534K0.0%+2.5%0.269% 11/13/2025 CM Management LLC2,100,000$3.44M2.9%-6.7%1.737% 11/7/2025Vanguard Group Inc.10,321,107$16.93M0.0%-2.4%8.880% 11/4/2025 Tyche Wealth Partners LLC195,868$321K0.1%-6.7%0.169% 10/29/2025 Wealth Enhancement Advisory Services LLC28,386$49K0.0%-17.2%0.024% 10/9/2025 Voya Investment Management LLC16,971$28K0.0%N/A0.015% 9/26/2025 Corient Private Wealth LLC60,000$44K0.0%+20.0%0.052% 8/15/2025 Corient Private Wealth LLC60,000$44K0.0%+20.0%0.052% 8/15/2025 Rubric Capital Management LP867,800$635K0.0%-83.5%0.749% 8/15/2025Bank of America Corp DE82,547$60K0.0%-22.4%0.071% 8/14/2025 Jane Street Group LLC63,313$46K0.0%N/A0.055% 8/13/2025 Stonepine Capital Management LLC62,700$46K0.0%-89.9%0.054% 8/13/2025 Invesco Ltd.208,271$152K0.0%+11.5%0.180% 8/13/2025 Panagora Asset Management Inc.794,329$581K0.0%N/A0.685% 8/13/2025 Tejara Capital Ltd698,770$511K0.2%+1.7%0.603% 8/12/2025 XTX Topco Ltd91,739$67K0.0%+65.3%0.079% 8/12/2025 JPMorgan Chase & Co.101,780$74K0.0%-85.7%0.088% 8/8/2025 Intech Investment Management LLC50,077$37K0.0%-46.6%0.043% 8/8/2025 Geode Capital Management LLC2,676,476$1.96M0.0%+0.8%2.309% 8/7/2025 Los Angeles Capital Management LLC387,916$284K0.0%-60.9%0.335% 8/6/2025 Savant Capital LLC60,553$44K0.0%-47.7%0.052% 7/29/2025 International Assets Investment Management LLC45,714$33K0.0%N/A0.039% 7/25/2025 CWM LLC39,937$29K0.0%-19.8%0.034% 7/23/2025 Tyche Wealth Partners LLC209,868$153K0.0%-21.0%0.181% 5/28/2025Strs Ohio324,000$261K0.0%N/A0.279% 5/21/2025Acadian Asset Management LLC196,927$158K0.0%+52,980.1%0.170% 5/16/2025AQR Capital Management LLC667,965$539K0.0%-45.0%0.576% 5/15/2025State of Wyoming49,099$40K0.0%-58.8%0.042% 5/14/2025Ieq Capital LLC75,020$61K0.0%+52.5%0.065% 5/14/2025Stonepine Capital Management LLC620,588$501K0.5%+148.2%0.535% 5/13/2025Tejara Capital Ltd687,218$555K0.2%-6.9%0.593% 5/12/2025Nuveen LLC95,056$77K0.0%N/A0.082% 5/12/2025Invesco Ltd.186,721$151K0.0%+182.7%0.161% 5/9/2025Deutsche Bank AG117,983$96K0.0%+198.9%0.102% 5/9/2025Charles Schwab Investment Management Inc.950,676$767K0.0%-2.7%0.820% 5/9/2025CM Management LLC2,147,500$1.73M1.7%+4.8%1.853% 5/8/2025Jefferies Financial Group Inc.317,625$256K0.0%-36.2%0.274% 5/1/2025CWM LLC49,793$40K0.0%+96.6%0.043% 4/30/2025Cerity Partners LLC54,676$44K0.0%+84.0%0.047% 3/17/2025Wealth Enhancement Advisory Services LLC30,847$43K0.0%+97.3%0.027% 2/17/2025Two Sigma Investments LP134,138$185K0.0%-80.3%0.116% 2/17/2025State of Wyoming119,270$165K0.0%+61.5%0.103% 2/17/2025Stonepine Capital Management LLC250,000$345K0.3%N/A0.216% 2/17/2025Tang Capital Management LLC3,650,000$5.04M0.3%+55.3%3.150% 2/17/2025Point72 Asset Management L.P.5,283,292$7.29M0.0%N/A4.559% Your $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.2/17/2025Millennium Management LLC1,049,603$1.45M0.0%+31.6%0.906% 2/17/2025Bridgeway Capital Management LLC203,000$280K0.0%-35.1%0.175% 2/17/2025Bank of America Corp DE153,332$212K0.0%-76.8%0.132% 2/14/2025Northern Trust Corp1,006,505$1.39M0.0%+12.2%0.869% 2/14/2025The Manufacturers Life Insurance Company37,903$52K0.0%N/A0.033% 2/14/2025Birchview Capital LP82,000$113K0.1%-78.0%0.071% 2/14/2025MetLife Investment Management LLC73,099$101K0.0%N/A0.063% 2/13/2025XTX Topco Ltd47,443$65K0.0%-90.0%0.041% 2/13/2025Bank of Montreal Can24,690$34K0.0%N/A0.021% 2/13/2025Cerity Partners LLC29,723$40K0.0%-33.3%0.026% CHRS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CHRS shares? During the previous two years, 82 institutional investors and hedge funds held shares of Coherus Oncology. The most heavily invested institutionals were Vanguard Group Inc. ($16.93M), Point72 Asset Management L.P. ($7.29M), Tang Capital Management LLC ($3.87M), CM Management LLC ($3.44M), Panagora Asset Management Inc. ($2.30M), Geode Capital Management LLC ($1.96M), and Northern Trust Corp ($1.39M).Learn more on Coherus Oncology's institutional investors. What percentage of Coherus Oncology's stock is owned by institutional investors? 72.82% of Coherus Oncology's stock is owned by institutional investors. Learn more on CHRS's institutional investor holdings. Which institutional investors have been buying Coherus Oncology's stock? Of the 67 institutional investors that purchased Coherus Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($5.28M), Tang Capital Management LLC ($1.30M), Panagora Asset Management Inc. ($1.04M), Los Angeles Capital Management LLC ($963.35K), Millennium Management LLC ($912.54K), AQR Capital Management LLC ($720.00K), and Stonepine Capital Management LLC ($620.59K). How much institutional buying is happening at Coherus Oncology? Institutional investors have bought a total of 5,147,662 shares in the last 24 months. This purchase volume represents approximately $6.70M in transactions. Which of Coherus Oncology's major shareholders have been selling company stock? Of the 22 institutional investors that sold Coherus Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.39M), Tang Capital Management LLC ($2.37M), JPMorgan Chase & Co. ($608.35K), Los Angeles Capital Management LLC ($603.60K), Stonepine Capital Management LLC ($557.89K), Vanguard Group Inc. ($249.41K), and LPL Financial LLC ($210.60K). How much institutional selling is happening at Coherus Oncology? Institutional investors have sold a total of 9,620,330 shares in the last 24 months. This volume of shares sold represents approximately $9.39M in transactions. Related Companies Septerna Major Shareholders Savara Major Shareholders CureVac Major Shareholders Alvotech Major Shareholders Phathom Pharmaceuticals Major Shareholders Schrodinger Major Shareholders Cronos Group Major Shareholders Xencor Major Shareholders Sana Biotechnology Major Shareholders Annexon Major Shareholders This page (NASDAQ:CHRS) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
